Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 7 von 38
Clinical microbiology and infection, 2019-08, Vol.25 (8), p.951-957
2019
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment
Ist Teil von
  • Clinical microbiology and infection, 2019-08, Vol.25 (8), p.951-957
Ort / Verlag
England: Elsevier Ltd
Erscheinungsjahr
2019
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
  • Carbapenem-resistant Acinetobacter baumannii (CRAB) has gained global notoriety as a critically important nosocomial pathogen. It mostly affects debilitated patients, causing pneumonia and bloodstream infections with high mortality rates. Difficulties in treating CRAB infections stem from a formidable resistance profile that leaves available only a few antibiotics of uncertain efficacy such as colistin and tigecycline. Despite the relentless attempts to improve therapeutic approaches (as depicted in colistin-oriented randomized clinical trials and the numerous observational studies), progress is still limited. We aim (a) to assist physicians to adapt therapeutic approaches in CRAB infections by considering all potentially available antimicrobials, and (b) to present directions for future investigations that emerge through treatment efforts in endemic settings. Articles and reviews from PubMed and Scopus databases; studies from ClinicalTrials.gov; presentations from ECCMID congresses and IDWeek meetings. The review provides a succinct overview of the important pharmacokinetic/pharmocodynamic parameters of relevant antimicrobial agents, a critical appraisal of randomized control trials and observational studies, suggestions for increasing the strength of observational studies and directions facilitating the choice of therapeutic regimens by severity of infection and status of the host. The lack of an optimal therapeutic regimen for CRAB thus far, as shown in this review, suggests the need to thoroughly investigate alternative approaches through carefully designed trials that should include all relevant drugs. Some of these alternative directions are indicated in the present review.
Sprache
Englisch
Identifikatoren
ISSN: 1198-743X
eISSN: 1469-0691
DOI: 10.1016/j.cmi.2019.03.014
Titel-ID: cdi_proquest_miscellaneous_2198560861

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX